Full metadata record
DC FieldValueLanguage
dc.contributor.authorHsu, Kai-Chengen_US
dc.contributor.authorChen, Yen-Fuen_US
dc.contributor.authorLin, Shen-Rongen_US
dc.contributor.authorYang, Jinn-Moonen_US
dc.date.accessioned2014-12-08T15:12:07Z-
dc.date.available2014-12-08T15:12:07Z-
dc.date.issued2011-02-15en_US
dc.identifier.issn1471-2105en_US
dc.identifier.urihttp://dx.doi.org/10.1186/1471-2105-12-S1-S33en_US
dc.identifier.urihttp://hdl.handle.net/11536/9292-
dc.description.abstractBackground: Pharmacological interactions are useful for understanding ligand binding mechanisms of a therapeutic target. These interactions are often inferred from a set of active compounds that were acquired experimentally. Moreover, most docking programs loosely coupled the stages (binding-site and ligand preparations, virtual screening, and post-screening analysis) of structure-based virtual screening (VS). An integrated VS environment, which provides the friendly interface to seamlessly combine these VS stages and to identify the pharmacological interactions directly from screening compounds, is valuable for drug discovery. Results: We developed an easy-to-use graphic environment, iGEMDOCK, integrating VS stages (from preparations to post-screening analysis). For post-screening analysis, iGEMDOCK provides biological insights by deriving the pharmacological interactions from screening compounds without relying on the experimental data of active compounds. The pharmacological interactions represent conserved interacting residues, which often form binding pockets with specific physico-chemical properties, to play the essential functions of a target protein. Our experimental results show that the pharmacological interactions derived by iGEMDOCK are often hot spots involving in the biological functions. In addition, iGEMDOCK provides the visualizations of the protein-compound interaction profiles and the hierarchical clustering dendrogram of the compounds for post-screening analysis. Conclusions: We have developed iGEMDOCK to facilitate steps from preparations of target proteins and ligand libraries toward post-screening analysis. iGEMDOCK is especially useful for post-screening analysis and inferring pharmacological interactions from screening compounds. We believe that iGEMDOCK is useful for understanding the ligand binding mechanisms and discovering lead compounds. iGEMDOCK is available at http://gemdock.life.nctu.edu.tw/dock/igemdock.php.en_US
dc.language.isoen_USen_US
dc.titleiGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysisen_US
dc.typeArticleen_US
dc.identifier.doi10.1186/1471-2105-12-S1-S33en_US
dc.identifier.journalBMC BIOINFORMATICSen_US
dc.citation.volume12en_US
dc.citation.issueen_US
dc.citation.epageen_US
dc.contributor.department生物科技學系zh_TW
dc.contributor.department生物資訊及系統生物研究所zh_TW
dc.contributor.departmentDepartment of Biological Science and Technologyen_US
dc.contributor.departmentInstitude of Bioinformatics and Systems Biologyen_US
dc.identifier.wosnumberWOS:000290221000034-
dc.citation.woscount22-
Appears in Collections:Articles


Files in This Item:

  1. 000290221000034.pdf

If it is a zip file, please download the file and unzip it, then open index.html in a browser to view the full text content.